evo756
·Code: EVO756
evo756: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Evommune, Inc. (EVMN) | Phase 2 |
Clinical Trials (1)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults With Atopic Dermatitis
Frequently asked questions
Who is developing evo756?
evo756 is being developed by Evommune, Inc..
How many clinical trials involve evo756?
BioSniper tracks 1 clinical trial involving evo756.
Get deeper analysis on evo756
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis